08:34 AM EST, 11/04/2024 (MT Newswires) -- Krystal Biotech ( KRYS ) reported Q3 net income Monday of $0.91 per diluted share, down from $2.79 a year earlier.
Analysts polled by Capital IQ expected $0.90.
Net revenue for the quarter ended Sept. 30 was $83.8 million, up from $8.6 million a year earlier.
Analysts surveyed by Capital IQ expected $83.1 million.
Price: 177.01, Change: +0.62, Percent Change: +0.35